Biocon Limited (BOM:532523)
India flag India · Delayed Price · Currency is INR
352.75
+4.05 (1.16%)
At close: Oct 9, 2025

Revenue by Product

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202003 - 2019
Period Ending
Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2003 - 2019
Biosimilars
89.29B
Log In
Log In
Log In
Log In
Upgrade
Biosimilars Growth
1.26%
Log In
Log In
Log In
Log In
Upgrade
Research
35.86B
Log In
Log In
Log In
Log In
Upgrade
Research Growth
4.32%
Log In
Log In
Log In
Log In
Upgrade
Generics
27.47B
Log In
Log In
Log In
Log In
Upgrade
Generics Growth
9.87%
Log In
Log In
Log In
Log In
Upgrade
Novels
-
Log In
Log In
Log In
Log In
Upgrade
Novels Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202003 - 2019
Period Ending
Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2003 - 2019
United States
70.42B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
9.10%
Log In
Log In
Log In
Log In
Upgrade
European Union (including Ireland)
38.48B
Log In
Log In
Log In
Log In
Upgrade
European Union (including Ireland) Growth
9.42%
Log In
Log In
Log In
Log In
Upgrade
Rest of the World
33.95B
Log In
Log In
Log In
Log In
Upgrade
Rest of the World Growth
6.89%
Log In
Log In
Log In
Log In
Upgrade
India
9.77B
Log In
Log In
Log In
Log In
Upgrade
India Growth
-39.27%
Log In
Log In
Log In
Log In
Upgrade
Ireland
-
Log In
Log In
Log In
Log In
Upgrade
Ireland Growth
-
Log In
Log In
Log In
Log In
Upgrade